SNSE Stock Analysis: Buy, Sell, or Hold?
SNSE - Sensei Biotherapeutics, Inc. Common Stock
$23.40
-0.36 (-1.52%)
▼
5d:
-13.2%
30d:
-23.35%
90d:
+164.11%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When SNSE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNSE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SNSE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SNSE is currently trading at $23.40, which is considered oversold relative to its 30-day fair value range of $26.82 to $32.24.
Technical Outlook: Technically, SNSE is in a strong uptrend. The price is currently testing key support at $22.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNSE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $50.00 (+113.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNSE is in a strong uptrend. The price is currently testing key support at $22.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNSE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $50.00 (+113.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$26.82 -
$32.24
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 113.7% below Wall St target ($50.00)
- CAUTION: 5-day price weakness (-13.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$26.82 -
$32.24
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$22.86
Resistance Level
$33.00
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.21
Wall Street Target
$50.00
(+113.7%)
Share & Embed Analysis
Last updated: May 09, 2026 4:37 PM ET
Data refreshes hourly during market hours. Next update: 5:37 PM
Data refreshes hourly during market hours. Next update: 5:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNSE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
James Peyer
SELL
3507 shares
2025-12-09
James Peyer
SELL
3105 shares
2025-12-08
James Peyer
SELL
16295 shares
2025-12-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 56 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 48 HOLD |
